Gel safe and acceptable as approach to preventing HIV from anal sex
A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE. The st ...
HIV & AIDS
Apr 03, 2013 |
not rated yet |
0
Daily HIV prevention approaches didn't work for African women in the VOICE study
Results of a major HIV prevention trial suggest that daily use of a product – whether a vaginal gel or an oral tablet – does not appear to be the right approach for preventing HIV in young, unmarried African women.
HIV & AIDS
Mar 04, 2013 |
not rated yet |
0
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
HIV & AIDS
Jan 30, 2013 |
not rated yet |
0
Adult antiviral drug effective in suppressing hepatitis B in teens
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December ...
Diseases, Conditions, Syndromes
Dec 05, 2012 |
5 / 5 (1) |
0
|
Study discovers unique feature of HIV that helps to create antibodies
Wits researchers have played a pivotal role in an AIDS study published today in the journal, Nature Medicine, which describes how a unique change in the outer covering of the virus found in two HIV infected South African women ...
HIV & AIDS
Oct 22, 2012 |
not rated yet |
1
Novel intravaginal ring shows promise in HIV prevention
A new 90-day intravaginal ring has been developed—that for the first time—enables the long-lasting vaginal delivery of tenofovir (TFV), the only topical prophylactic shown to be effective at reducing the sexual transmission ...
HIV & AIDS
Oct 16, 2012 |
not rated yet |
0
NIH-funded analysis estimates effective PrEP dosing
Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP. The level ...
HIV & AIDS
Sep 13, 2012 |
not rated yet |
0
UNAIDS welcomes US approval of drug to stop HIV
The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.
HIV & AIDS
Jul 17, 2012 |
not rated yet |
0
Pills to prevent HIV raise many questions: studies
Various trials examining the use of anti-retroviral drugs in healthy heterosexuals as a way to prevent HIV have shown drastically different results, research showed Wednesday.
HIV & AIDS
Jul 11, 2012 |
not rated yet |
0
Drugs used to treat HIV also reduce risk of HIV infection
People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers ...
HIV & AIDS
Jul 10, 2012 |
not rated yet |
0
New once-daily 'Quad' pill for HIV is safe, effective alternative to traditional antiretroviral regimens
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. ...
HIV & AIDS
Jun 28, 2012 |
not rated yet |
0
Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...
HIV & AIDS
May 17, 2012 |
5 / 5 (1) |
0
Anti-HIV drug tenofovir is safe to take during pregnancy
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
US health advisors mull AIDS prevention pill (Update)
US health advisers on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people.
HIV & AIDS
May 10, 2012 |
not rated yet |
0
Anti-HIV drug use during pregnancy does not affect infant size, birth weight
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens ...
HIV & AIDS
May 02, 2012 |
not rated yet |
0
|
